These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors. Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and molecular docking of new [1,2,4] triazolo[4,3-a]quinoxaline derivatives as anticancer agents targeting VEGFR-2 kinase. Alsaif NA; Elwan A; Alanazi MM; Obaidullah AJ; Alanazi WA; Alasmari AF; Albassam H; Mahdy HA; Taghour MS Mol Divers; 2022 Aug; 26(4):1915-1932. PubMed ID: 34460053 [TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of some new 6-bromo-2-(pyridin-3-yl)-4-substituted quinazolines as multi tyrosine kinase inhibitors. Farouk AKBAW; Abdelrasheed Allam H; Rashwan E; George RF; Abbas SE Bioorg Chem; 2022 Nov; 128():106099. PubMed ID: 35994884 [TBL] [Abstract][Full Text] [Related]
9. New [1,2,4]triazolo[4,3-c]quinazoline derivatives as vascular endothelial growth factor receptor-2 inhibitors and apoptosis inducers: Design, synthesis, docking, and antiproliferative evaluation. Azab AE; Alesawy MS; Eldehna WM; Elwan A; Eissa IH Arch Pharm (Weinheim); 2022 Oct; 355(10):e2200133. PubMed ID: 35822666 [TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of new 2-oxoquinoxalinyl-1,2,4-triazoles as antitumor VEGFR-2 inhibitors. Zengin M; Unsal Tan O; Arafa RK; Balkan A Bioorg Chem; 2022 Apr; 121():105696. PubMed ID: 35217379 [TBL] [Abstract][Full Text] [Related]
11. Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation. Eissa IH; El-Helby AA; Mahdy HA; Khalifa MM; Elnagar HA; Mehany ABM; Metwaly AM; Elhendawy MA; Radwan MM; ElSohly MA; El-Adl K Bioorg Chem; 2020 Dec; 105():104380. PubMed ID: 33128967 [TBL] [Abstract][Full Text] [Related]